Parallel Advisors’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $281K | Sell |
1,439
-353
| -20% | -$73.2K | ﹤0.01% | 1063 |
|
|
2026
Q1 | $402K | Buy |
1,792
+24
| +1% | +$5.98K | 0.01% | 808 |
|
|
2025
Q4 | $426K | Sell |
1,768
-157
| -8% | -$40.2K | 0.01% | 746 |
|
|
2025
Q3 | $527K | Buy |
1,925
+113
| +6% | +$30.9K | 0.01% | 642 |
|
|
2025
Q2 | $468K | Buy |
1,812
+94
| +5% | +$22.4K | 0.01% | 658 |
|
|
2025
Q1 | $385K | Buy |
1,718
+21
| +1% | +$4.9K | 0.01% | 683 |
|
|
2024
Q4 | $388K | Buy |
1,697
+102
| +6% | +$24.6K | 0.01% | 667 |
|
|
2024
Q3 | $389K | Buy |
1,595
+177
| +12% | +$39.6K | 0.01% | 661 |
|
|
2024
Q2 | $272K | Buy |
1,418
+34
| +2% | +$6.9K | 0.01% | 740 |
|
|
2024
Q1 | $274K | Buy |
1,384
+282
| +26% | +$51.7K | 0.01% | 739 |
|
|
2023
Q4 | $190K | Buy |
1,102
+147
| +15% | +$22.6K | 0.01% | 824 |
|
|
2023
Q3 | $141K | Sell |
955
-293
| -23% | -$53K | ﹤0.01% | 924 |
|
|
2023
Q2 | $273K | Sell |
1,248
-5
| -0.4% | -$1.11K | 0.01% | 654 |
|
|
2023
Q1 | $274K | Sell |
1,253
-376
| -23% | -$81.6K | 0.01% | 637 |
|
|
2022
Q4 | $339K | Sell |
1,629
-138
| -8% | -$30.3K | 0.01% | 517 |
|
|
2022
Q3 | $386K | Sell |
1,767
-182
| -9% | -$41.4K | 0.02% | 460 |
|
|
2022
Q2 | $409K | Buy |
1,949
+43
| +2% | +$9.15K | 0.02% | 459 |
|
|
2022
Q1 | $475K | Sell |
1,906
-39
| -2% | -$9.43K | 0.02% | 445 |
|
|
2021
Q4 | $507K | Buy |
1,945
+136
| +8% | +$35.3K | 0.02% | 437 |
|
|
2021
Q3 | $477K | Buy |
1,809
+158
| +10% | +$43.2K | 0.02% | 415 |
|
|
2021
Q2 | $407K | Buy |
1,651
+43
| +3% | +$9.04K | 0.02% | 441 |
|
|
2021
Q1 | $312K | Buy |
1,608
+59
| +4% | +$11.8K | 0.01% | 477 |
|
|
2020
Q4 | $329K | Sell |
1,549
-82
| -5% | -$16.4K | 0.02% | 425 |
|
|
2020
Q3 | $280K | Buy |
1,631
+70
| +4% | +$12.9K | 0.02% | 448 |
|
|
2020
Q2 | $299K | Buy |
1,561
+40
| +3% | +$6.54K | 0.02% | 422 |
|
|
2020
Q1 | $224K | Buy |
1,521
+36
| +2% | +$5.73K | 0.02% | 413 |
|
|
2019
Q4 | $230K | Hold |
1,485
| – | – | 0.02% | 464 |
|
|
2019
Q3 | $201K | Buy |
1,485
+261
| +21% | +$34.2K | 0.02% | 476 |
|
|
2019
Q2 | $149K | Buy |
1,224
+59
| +5% | +$6.54K | 0.01% | 529 |
|
|
2019
Q1 | $121K | Buy |
1,165
+837
| +255% | +$86.4K | 0.01% | 550 |
|
|
2018
Q4 | $37K | Buy |
328
+193
| +143% | +$20.7K | 0.01% | 867 |
|
|
2018
Q3 | $16K | Hold |
135
| – | – | ﹤0.01% | 1248 |
|
|
2018
Q2 | $13K | Hold |
135
| – | – | ﹤0.01% | 1235 |
|
|
2018
Q1 | $13K | Hold |
135
| – | – | ﹤0.01% | 1179 |
|
|
2017
Q4 | $11K | Hold |
135
| – | – | ﹤0.01% | 1270 |
|
|
2017
Q3 | $11K | Hold |
135
| – | – | ﹤0.01% | 1260 |
|
|
2017
Q2 | $10K | Buy |
135
+17
| +14% | +$1.22K | ﹤0.01% | 1321 |
|
|
2017
Q1 | $8K | Buy |
118
+12
| +11% | +$829 | ﹤0.01% | 1319 |
|
|
2016
Q4 | $7K | Buy |
+106
| New | +$6.49K | ﹤0.01% | 1255 |
|
Other funds holding RMD
Parallel Advisors's RMD Position: Q2 2026 in Review
Parallel Advisors reduced its ResMed (RMD) stake by 20% in Q2 2026, selling an estimated $73.2K and leaving 1,439 shares worth $281K. The position accounts for ﹤0.01% of the portfolio, ranked #1063.
Parallel Advisors first reported a position in RMD in Q4 2016 and has held it in 39 quarters since. The position peaked at $527K in Q3 2025. 448 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Parallel Advisors held 1,439 shares of ResMed worth $281K as of Q2 2026.
- Parallel Advisors sold 353 ResMed shares in Q2 2026, an estimated $73.2K.
- ResMed made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #1063 holding.
- Parallel Advisors first reported a position in ResMed in Q4 2016 and has held it in 39 quarters since.
- Parallel Advisors's ResMed position peaked at $527K in Q3 2025.
- 448 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.